SAI
EW icon

Savvy Advisors Inc’s Edwards Lifesciences EW Stock Holding History

Savvy Advisors Inc’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
13,537
+8,952
+195% +$750K 0.03% 461
2026
Q1 		$367K Buy
4,585
+2,118
+86% +$175K 0.01% 784
2025
Q4 		$210K Buy
+2,467
New +$202K 0.01% 935
2025
Q3 		– Sell
-2,587
Closed -$202K – 828
2025
Q2 		$202K Buy
+2,587
New +$193K 0.01% 612

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Savvy Advisors Inc's EW Position: Q2 2026 in Review

Savvy Advisors Inc increased its Edwards Lifesciences (EW) stake by 195% in Q2 2026, buying an estimated $750K and bringing the position to 13,537 shares worth $1.22M. The position accounts for 0.03% of the portfolio, ranked #461.

Savvy Advisors Inc first reported a position in EW in Q2 2025 and has held it in 4 quarters since. 1,338 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Savvy Advisors Inc held 13,537 shares of Edwards Lifesciences worth $1.22M as of Q2 2026.
  • Savvy Advisors Inc bought 8,952 Edwards Lifesciences shares in Q2 2026, an estimated $750K.
  • Edwards Lifesciences made up 0.03% of Savvy Advisors Inc's portfolio in Q2 2026, its #461 holding.
  • Savvy Advisors Inc first reported a position in Edwards Lifesciences in Q2 2025 and has held it in 4 quarters since.
  • 1,338 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Savvy Advisors Inc's 13F filing for Q2 2026, filed 3 Aug 2026.